Zhongzheng International Sees Narrowed Loss Despite Sharp Revenue Decline

An announcement from Zhongzheng International Company Limited ( (HK:0943) ) is now available.

Zhongzheng International Company Limited has warned that it will remain loss-making from continuing operations for the six months ended 31 December 2025, but expects its consolidated loss to narrow sharply to between HK$13.5 million and HK$14.5 million from HK$36.9 million a year earlier. The improvement comes despite a 35.3% drop in total revenue to about HK$41.4 million, driven by weaker performance in its healthcare and household segment, as the group benefited from the absence of prior-year impairment charges and booked a HK$9.6 million gain from capitalising shareholder loans.

The latest figures, based on unaudited management accounts ahead of the interim results due on 27 February 2026, underscore an ongoing restructuring of Zhongzheng’s balance sheet rather than an underlying recovery in operating performance. While reduced losses and debt capitalisation may ease financial pressure and support the company’s capital structure, the revenue decline highlights continued operational challenges in its core markets, and the board has cautioned shareholders and potential investors to exercise care when trading its shares.

The most recent analyst rating on (HK:0943) stock is a Hold with a HK$0.24 price target. To see the full list of analyst forecasts on Zhongzheng International Company Limited stock, see the HK:0943 Stock Forecast page.

More about Zhongzheng International Company Limited

Zhongzheng International Company Limited, incorporated in Bermuda and listed in Hong Kong, operates through a healthcare and household business segment that forms the core of its revenue base. The group’s activities are concentrated in providing healthcare and household products and services, making it sensitive to consumer demand and sector-specific headwinds in these markets.

Average Trading Volume: 428,574

Technical Sentiment Signal: Hold

Current Market Cap: HK$391.9M

For a thorough assessment of 0943 stock, go to TipRanks’ Stock Analysis page.